We evaluated mean IgA responses to Msg constructs by CD4 count, viral load, antivirals, and PCP prophylaxis, finding that taking antiretrovirals and/or PCP prophylaxis was associated with statistically significantly higher mean IgA responses to Msg (S1 Table). The gene discussed is CD4; the disease is pneumocystosis.